Norway· NO-ID_32984B53-7AB4-4C7F-8CCA-D8BED5E21647
Telebrix Gastro
A ioxitalaminsäure product containing ioxitalamate meglumine, registered in Norway by Guerbet. The same ATC class is registered in 5 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ioxitalaminsäure is registered in 5 of 19 countries.
Countries holding a registration under ATC V08AA05 (ioxitalaminsäure), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Ioxitalaminsäure · ATC V08AA05
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Ioxitalamate Meglumine
- Manufacturer
- Guerbet
- Country
- Norway (NO)
- ATC code
- V08AA05
- ATC class
- Ioxitalaminsäure
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 2
- no_merkevare_idID_32984B53-7AB4-4C7F-8CCA-D8BED5E21647
- no_varenummer27676110 x 100
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ioxitalaminsäure in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTelebrix 30 Meglumine 300 mg I/mlGuerbet
- GermanyTelebrix GastroEurocontrast Gmbh
- CzechiaTELEBRIX GASTROGuerbet, Roissy CdG Cedex
- FranceTELEBRIX GASTRO (300 mg l/mL), solution pour administration par voie orale ou rectaleGUERBET
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Telebrix Gastro
- Czechia · Telebrix Gastro
- Germany · Telebrix Gastro
- France · Telebrix Gastro
- Hungary · Telebrix Gastro
- Luxembourg · Telebrix Gastro
- Netherlands · Telebrix Gastro
- Portugal · Telebrix Gastro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/57184e9c-42bd-4aa4-b4ba-ea7e27287cdd GET /v1/drugs/57184e9c-42bd-4aa4-b4ba-ea7e27287cdd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til mikstur/rektalvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Joksitalamsyre",
"merkevare_id": "ID_32984B53-7AB4-4C7F-8CCA-D8BED5E21647",
"name_form_strength": "Telebrix Gastro kons til mikst/rektalvæske, oppl 300 mg I/ml",
"prescription_group": "C"
}See everything about ioxitalaminsäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.